D. Jp, Epidémiologie de l'infarctus du myocarde EMC ? Cardiologie Angéiologie, 2005.

I. Platelet-glycoprotein, IIIa inhibition with coronary stenting for acute myocardial infarction, N Engl J Med, vol.344, pp.1895-1903, 2001.

S. Gw, G. Cl, and C. Da, for the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) investigators. Comparison of angioplasty with stenting, with or without abciximab, acute myocardial infarction

M. O. Donoghue, E. M. Antman, and E. Braunwald, The Efficacy and Safety of Prasugrel With and Without a Glycoprotein IIb/IIIa Inhibitor in Patients With Acute Coronary Syndromes Undergoing Percutaneous Intervention: A TRITON?TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel? Thrombolysis In Myocardial Infarction 38, Analysis Journal of the American College of Cardiology, vol.54, issue.8, 2009.